MAPT and Alzheimer disease: Thus, various pathological mechanisms lead to tauopathy development, such as Tau mis-splicing in some cases of FTDP-17 and the amyloid cascade in AD, explaining why these pathologies, although clinically different, share several molecular features, as described in this review and schematized in Figure 4.